Page last updated: 2024-10-29

imipramine and Binge Alcohol Consumption

imipramine has been researched along with Binge Alcohol Consumption in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"In an animal model of binge drinking that exhibits abstinence-induced behaviors reminiscent of negative affective states, the triple monoamine uptake inhibitor, amitifadine, produced a selective, dose dependent attenuation of binge drinking."1.38Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. ( Basile, AS; June, HL; Kelly, T; Skolnick, P; Warnock, KT; Yang, AR; Yi, HS, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Warnock, KT1
Yang, AR1
Yi, HS1
June, HL2
Kelly, T1
Basile, AS1
Skolnick, P1

Other Studies

1 other study available for imipramine and Binge Alcohol Consumption

ArticleYear
Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology.
    Pharmacology, biochemistry, and behavior, 2012, Volume: 103, Issue:1

    Topics: Affect; Alcoholism; Animals; Aza Compounds; Binge Drinking; Biogenic Monoamines; Bridged Bicyclo Com

2012